Table 2.
Correlation table for continuous variables and their association with cholinesterase assessed by using Spearman–Rho correlation coefficient
| Total study population (n = 191) | Correlation, r | P value | |
|---|---|---|---|
| Age, median years (IQR) |
62 (51–69) |
-0.05 |
0.535 |
| SAPS II at ICU admission, n (%) |
44 (31–60) |
-0.05 |
0.530 |
| EuroSCORE (additive), points (IQR) |
10 (6–13) |
-0.23 |
0.001 |
| Procedure duration, hours (IQR) |
7.2 (4.8-9.0) |
0.12 |
0.113 |
| ECMO duration, median days (IQR) |
4 (2–6) |
-0.17 |
0.016 |
| Time on mechanical ventilation, median days (IQR) |
11 (4–19) |
0.06 |
0.419 |
| Creatinine, mg/dl (IQR) |
1.36 (1.10–1.88) |
-0.12 |
0.098 |
| Estimated GFR, ml/min/1.73 m2 (IQR) |
57 (38–77) |
0.11 |
0.138 |
| Albumin, g/L (IQR) |
36 (28–42) |
0.59 |
<0.001 |
| ASAT, U/L (IQR) |
39 (26–111) |
-0.20 |
0.005 |
| ALAT, U/L (IQR) |
32 (18—61) |
-0.03 |
0.734 |
| γ-GT, U/L (IQR) | 59 (33—121) | -0.14 | 0.049 |
Continuous data are presented as median (interquartile range), and their association with cholinesterase was assessed by using Spearman–Rho correlation coefficient. ECMO, extracorporeal membrane oxygenation; IABP, intraaortic balloon pump; GFR, glomerular filtration rate estimated by using Cockcroft-Gault formula; SAPS II, simplified acute physiology score II.
Bold typefaces indicates statistical significance (P < 0.05).